Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (171-180 of 293) with videos related to

Pageof 30
Sort By:
HIV Medicine|November 18, 2025
Anal cancer screening in men who have sex with men living with HIV: The pilot of anal screening study (PASS)Clare E F Dyer, Fengyi Jin, Jennifer M Roberts, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Missed opportunities in HCV care: Trends in late diagnosis and treatmentShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Missed opportunities in HCV care: Trends in late diagnosis and treatment" [JHEP Reports 7 (2025) 101474]Shane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2024
Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT StudyPhyo Pyae Nyein, Kathy Petoumenos, Margaret Borok, et al.
Drug and Alcohol Review|May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based studyHeather Valerio, Maryam Alavi, Alison D Marshall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 14, 2021
One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record reviewLiam S Acheson, Krista J Siefried, Brendan Clifford, et al.
JHEP Reports : Innovation in Hepatology|September 19, 2022
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South WalesSyed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CG V Matthews, M Hellard, P Haber, et al.
AIDS (London, England)|March 4, 2026
Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trialPhyo Pyae Nyein, Mark W Donoghoe, Nnakelu Eriobu, et al.
Health Science Reports|April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trialJason Grebely, Phillip Read, Evan B Cunningham, et al.
Pageof 30

Showing results (171-180 of 293) with videos related to

Sort By:
Pageof 30
HIV Medicine|November 18, 2025
Anal cancer screening in men who have sex with men living with HIV: The pilot of anal screening study (PASS)Clare E F Dyer, Fengyi Jin, Jennifer M Roberts, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Missed opportunities in HCV care: Trends in late diagnosis and treatmentShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Missed opportunities in HCV care: Trends in late diagnosis and treatment" [JHEP Reports 7 (2025) 101474]Shane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2024
Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT StudyPhyo Pyae Nyein, Kathy Petoumenos, Margaret Borok, et al.
Drug and Alcohol Review|May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based studyHeather Valerio, Maryam Alavi, Alison D Marshall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 14, 2021
One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record reviewLiam S Acheson, Krista J Siefried, Brendan Clifford, et al.
JHEP Reports : Innovation in Hepatology|September 19, 2022
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South WalesSyed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CG V Matthews, M Hellard, P Haber, et al.
AIDS (London, England)|March 4, 2026
Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trialPhyo Pyae Nyein, Mark W Donoghoe, Nnakelu Eriobu, et al.
Health Science Reports|April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trialJason Grebely, Phillip Read, Evan B Cunningham, et al.
Pageof 30